Psychiatric morbidity and its recognition by doctors in patients with cancer by Fallowfield, L et al.
The stress associated with the diagnosis and treatment of cancer
can cause significant psychiatric morbidity. Prevalence estimates
vary depending on the assessment measures employed and the
diagnostic criteria applied but reports for the past 3 decades
(Maguire et al, 1978; Derogatis et al, 1983; Massie and Holland,
1990; Hopwood and Stephens, 2000) suggest that 25–50% of
patients have psychological problems, with at least 25% meeting
the criteria for either a major depressive disorder or adjustment
disorder with depressed mood (Sellick and Crooks, 1999). These
figures seem fairly consistent whether self-report questionnaires or
standardized interviews are used and apply across all tumour sites
and stages of disease, although there are some reports that the risk
of major depression increases with recurrence (Cella et al, 1990;
Hall et al, 1996) advanced disease, (Breitbart, 1995) and with
increasing disability and pain (Passik et al, 1998). Evidence that
any other patient or disease characteristics are associated with an
increased likelihood of psychological morbidity is indeterminate. 
Many of the psychological problems suffered by patients could
be prevented or at least ameliorated if the communication skills of
clinicians were better. In one study of women with breast cancer,
those who were satisfied with the way in which the surgeon
discussed their diagnosis and treatment options evidenced less
psychiatric morbidity during the first year post treatment and at 2
and 3 year follow up (Fallowfield et al, 1990; Fallowfield and
Hall, 1994). If psychological problems are recognized by health-
care professionals then patients can be referred on for appropriate
and effective interventions (Fallowfield, 1995). Given the extent
of psychiatric morbidity and the proven efficacy of many different
types of intervention for adult cancer patients (Meyer and Mark,
1995; Sheard and Maguire, 1999) this should form an important
part of effective clinical management. Unfortunately several
studies have shown that oncologists are not especially skilled at
either discussing psychological problems in general, or at recog-
nizing anxiety or depression (Hardman et al, 1989; Ford et al,
1994; Newell et al, 1998; Passik et al, 1998). Most published data
suggest that doctors’ ability to accurately detect psychological
morbidity in patients is often little better than that due to chance. 
Although the recognition of psychological morbidity is often
hampered by the unwillingness of patients to disclose emotional
concerns, the doctors are frequently reluctant to probe these areas
satisfactorily (Hardman et al, 1989; Hopwood et al, 1991; Ford
et al, 1996). For example in one study in which oncologists were
tape-recorded giving patients bad news about their diagnoses and
prognoses, the levels of psychological probing were low. When
patients did volunteer psychological concerns, these were not
pursued as oncologists kept the dialogue focused on a rigid
biomedical agenda (Ford et al, 1996). Far too often psychological
symptoms in patients are discounted as a normal consequence of
having cancer (Fallowfield, 1988, 1990; Newell et al, 1998). 
Even if doctors possess appropriate communication skills they
often fail to utilize them given the stressful and difficult clinical
environments in which many work. There are too few doctors
seeing too many patients in UK cancer clinics with the added pres-
sures of throughput and cost containment burdening them further.
Furthermore surveys in the UK and US have shown that psychi-
atric morbidity and emotional burnout are almost as common in
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http://www.bjcancer.comoncologists as in the patients whom they treat (Whippen and
Canellos, 1991; Ramirez et al, 1995). Approximately 29% of
British oncologists had above threshold scores (Ramirez et al,
1996) on a psychiatric screening inventory (GHQ12) (Goldberg
and Williams, 1988). The under-trained, over-stretched and under-
resourced doctor is unlikely to actively elicit information about the
psychosocial impact that cancer and its treatment exerts on
patients. 
We report data from a study establishing the prevalence of
probable psychiatric morbidity in a heterogeneous sample of 2297
patients with cancer seen in cancer clinics throughout the UK. We
also report the ability of their doctors to detect this morbidity and
the characteristics of both patient and doctor that were associated
with detection. 
METHODS 
143 doctors from 34 different cancer centres and hospitals in the
UK took part in the study. All were participating in a randomized
trial of a communication skills training programme for cancer
specialists or specialists in training. Data about psychological
morbidity and its recognition were collected as an outcome
measure in part of the main trial. The specialty, seniority and sex
of doctors are shown in Table 1. Participants included clinical,
medical or surgical oncologists, 2 chest physicians who dealt
primarily with lung cancer, a dermatologist with a specialist
interest in melanoma and a palliative care physician. 
2681 consecutive patients, waiting in out-patient clinics, were
invited to join the main communication skills trial; of these 2331
(85%) gave their written consent to participate. The demographic
characteristics of the 2297 patients with completed questionnaires
for the detection of psychological morbidity study are shown in
Table 2. 
Procedure 
Prior to seeing the doctor consenting patients completed the 12
item version of the General Health Questionnaire (GHQ12). This
instrument has high internal reliability and validity and was
designed specifically as a brief screening instrument in large popu-
lation studies (Goldberg and Williams, 1988). A conventional
scoring method was employed with a threshold of 4 or more indi-
cating probable caseness for psychological morbidity. 
The doctors were blinded to the patients’ GHQ scores but they
were aware that the assessment was being made. Immediately
following the patients’ videotaped consultations, the doctors
completed visual analogue scales (VAS) utilized in previous publi-
cations by ourselves and other authors in this type of study (Ford 
et al, 1994). On the VAS, the doctors self-rated various aspects of the
interview including their perceptions of patients’ psychological
status at the beginning and end of the interview. The doctors’ VAS
ratings recorded for the patients at the end of their consultations
were compared with each patient’s GHQ score. 
RESULTS 
Statistics 
Standard non-parametric and parametric statistical tests, c2 and
ANOVA were used throughout, with Bonferroni corrections
for multiple comparisons applied as appropriate, using SPSS
packages. 
Probable psychiatric morbidity 
Table 2 shows that 837/2297 (36.4%) of the patient group as a
whole scored above threshold on the GHQ12 indicating probable
psychiatric morbidity. Caseness was significantly higher in
patients 31–50 years old (c2 = 9, df = 3, P = 0.029) and in patients
receiving palliative rather than curative treatment or those in
remission (c2 = 40.75, df = 3, P = 0.0001). The percentage of
patients with high threshold scores within different cancer sites is
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Table 1 Characteristics of doctors (n = 143) 
Characteristics n
Sex 
Male 105 
Female 38 
Previous communication skills training 
Yes 6 
No 137 
Seniority 
Junior (Specialist registrar) 48 
Senior (Consultant) 95 
Speciality 
Medical oncology 54 
Clinical oncology 60 
Surgical oncology 25 
Dermatology, palliative care, chest medicine 4 
Table 2 Characteristics of patients with GHQ ³ 4 
GHQ ³ 4 N (%) 
Total sample n = 2297 837 (36.4) 
Age (years) n (%) 
≤ 30 112 (5.1) 31 (27.7) 
31–50 572 (26.1) 232 (40.6) 
51–70 1071 (48.9) 393 (36.7) 
>70 433 (19.8) 147 (33.9) 
Missing 109 
Sex 
Male 881 (38.4) 300 (34.1) 
Female 1416 (61.6) 537 (37.9) 
Aim of treatment 
Curative 944 (41.1) 299 (31.7) 
Palliative 849 (37.0) 379 (44.6) 
Remission 215 (9.4) 61 (28.4) 
Uncertain 289 (12.6) 98 (33.9) 
CA site 
Breast 662 (28.8) 238 (36.0) 
GI 446 (19.4) 158 (35.4) 
Skin 81 (3.6) 22 (27.2) 
Urological 202 (8.8) 69 (34.2) 
CNS 71 (3.1) 36 (50.7) 
Gynae 153 (6.7) 55 (35.9) 
Head & Neck 83 (3.6) 33 (39.8) 
Haematology 196 (8.5) 66 (33.7) 
Lung 172 (7.5) 76 (44.2) 
Musc/skeletal 38 (1.7) 14 (36.8) 
Unknown 10 33 (1.4) 16 (48.5) 
Other 32 (1.4) 13 (40.6) 
Benign 128 (5.6) 41 (32.0) 
*All patients with valid GHQ (≤ 3 items omitted) and a doctor’s rating for
distress at end of consultation. highest in those with CNS malignancies, unknown primaries and
lung cancer. Of the patients seen by medical oncologists (includes
2 chest physicians, a dermatologist and palliative care specialist
for ease of analysis), 332/948(35%) were probable cases, as were
385/983(39.2%) seen by clinical oncologists, and 120/366(32.8%)
seen by surgeons. The number of probable cases seen by each
specialist group differed significantly with clinical oncologists
having more probable cases than the other two groups (c2 = 6.09,
df = 2, P = 0.048). 
Doctors detection rates 
The mean number of consultations per doctor was 16 (SD 5, range
5–27) and each doctor saw on average 6 patients (SD 3, range 
0–17) who scored above threshold. The more senior clinicians
(consultants) saw a significantly greater number of patients with
high GHQ scores than did the more junior specialist registrars (c2
= 5.56, df = 1, P = 0.018). Specificity, sensitivity and misclassifi-
cation rates are shown in Table 3. Overall the sensitivity or true
positive rate of the doctors was 28.87%. Specificity or true nega-
tive rate was 84.79% and misclassification rate was 34.7%. These
figures show that the doctors’ predominant tendency was to assess
patients as not distressed. Only 242 of the 827 patients with high
scores were recognized as having probable psychiatric morbidity
and therefore 595 patients with likely problems were missed. 1238
patients were correctly assessed as unlikely to have significant
levels of distress to warrant a diagnosis of anxiety or depression
but 222 patients with low GHQ scores were identified by the clin-
icians as probable cases of psychiatric morbidity. So overall a
misclassification rate of 34.7% means that for 797 patients a
potentially incorrect assessment was made. 
There was no significant difference in sensitivity and specificity
rates according to specialty but there was a difference in misclassi-
fication rates (F = 3.15, df = 2, P = 0.046); the clinical oncologists
who saw more high GHQ scorers, also had a significantly higher
misclassification rate than did surgeons and medical oncologists
(Bonferroni test, P < 0.05). When seniority was taken into consid-
eration, there was no effect of specialty amongst more junior
doctors; the difference remained only for the senior clinical oncol-
ogists who misclassified a significantly greater number of patients
as distressed (Bonferroni test, P < 0.05). 
When data were scrutinized according to whether or not the
patient had been seen by the doctor on a previous occasion there
was no effect on detection rates. There were no differences in
detection rates according to the sex of the doctor. 
Length of consultations 
The mean length of consultations was 13.49 minutes, (mode 10
min, range 1–67 min). There was a significant difference in mean
times between groups (F = 42.15, df = 3, P = 0.0000) with the
surgeons having the shortest consultation times (Bonferroni P <
0.05). Overall there was a significant difference in the length of
consultation and the detection rates of probable psychiatric
morbidity (F = 52.93, df = 3, P = 0.0000). Patients who were true
positives had longer mean consultations than did those who were
false negatives (17.68 mins v 14.94 mins, t = 4.08, df = 818, P =
0.0000, SE = 0.672, CI: 1.42–4.05). 
DISCUSSION 
These results from a very large heterogeneous sample of patients
with cancer reinforce previous findings from earlier, smaller
studies that psychological morbidity is still common and that much
of it goes unrecognised and is not therefore treated. The doctors
were all aware that the psychological status of their patients was
being assessed and that their interactions were being videotaped.
Therefore it is likely that the situation when doctors are not being
monitored is even bleaker. Patients with problems that could
potentially be ameliorated are not getting the psychological
support required. Many clinicians would claim that they leave this
area for their specialist nurses to pick up on, but there is little
evidence that such nurses screen effectively for psychological
morbidity either (Heaven and Maguire, 1997). Furthermore, many
nurses are just as burdened as the doctors by the volume of patients
and time pressures, so many patients with psychological problems
get missed. Time did appear to be a relevant factor as true positive
patients i.e. those who were correctly identified by the doctor, had
significantly longer consultations than those who were false nega-
tives, that is patients with probable psychological morbidity who
were missed by the doctors. Until an associated project looking at
utterance by utterance analysis of the videotaped interactions is
completed, we will not know if the increased length of time was
due to the doctors eliciting the psychological problems and
exploring them effectively in the recognized cases; alternatively
patients who were missed might have given clear cues during the
consultation which the doctor failed to acknowledge, or maybe
chose not to follow-up. It has been shown in a general practise
setting that doctors who recognise depression communicate rather
differently from those who do not, in particular they ask more open
questions about feelings and affect (Carney et al, 1999). We also
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Table 3 Specificity, sensitivity and misclassification rates by sex, seniority and specialty of clinician 
Specificity Sensitivity Misclassification 
n % SD CI % SD CI % SD CI 
Total sample 143 84.79 17.44 81.91–87.67 28.87 25.29 24.69–33.05 34.70 13.79 32.42–36.98 
Male 105 84.51 16.44 81.32–87.69 29.58 24.62 24.82–34.35 34.69 12.83 32.21–37.17 
Female 38 85.59 20.18 78.96–92.22 26.91 27.31 17.94–35.89 34.74 16.35 29.37–40.12 
Sp Registrar 48 87.41 16.31 82.68–92.15 26.85 27.81 18.78–34.93 32.23 12.72 28.54–35.93 
Consultant 95 83.47 17.92 79.82–87.12 29.89 24.00 25.00–34.79 35.95 14.21 33.06–38.85 
Med Oncologist 58 80.85 19.08 75.83–85.87 33.09 23.84 26.82–39.36 34.00 15.32 29.97–38.03 
Clinical Oncologist 60 86.51 17.02 82.12–90.91 25.31 26.57 18.44–32.17 37.52 13.06 34.15–40.89 
Surgeon 25 89.82 12.32 84.73–94.90 27.65 24.95 17.35–37.95 29.57 10.05 25.43–33.72 
These were calculated by taking the mean score for each doctor and then the mean for each variable know from a previous study of 178 senior doctors in cancer medi-
cine attending communication skills courses that eliciting and then
dealing effectively with patients’ emotional problems caused them
considerable difficulty (Fallowfield et al, 1998). 
There are at least 2 potential problems with the interpretation of
our results that need acknowledgement. First any screening instru-
ment by definition, will have imperfect sensitivity and specificity
itself, although there have been at least 6 studies showing that both
of these are very good for the GHQ. There is no true gold standard
against which to assess the clinician’s ability to detect psychiatric
morbidity, but (Goldberg et al, 1993) provide an example of how
the GHQ12 has been used successfully in studies aimed at helping
general practitioners to identify distress in their patients. Similarly
the GHQ28 was used to evaluate physicians’ skills in reducing
patients’ distress in an RCT of a training intervention in the US
(Roter et al, 1995). Nevertheless in our study at least some of the
clinicians’ false-negative patients, could in fact have been rated
following an accurate clinical appraisal of transient distress and
dysfunction; such patients might have an above threshold score on
the GHQ but might not have a psychiatric illness following a stan-
dardized psychiatric interview. We also recognize that the content
of the consultation may have reduced or increased the patients’
overt signs of distress making doctors appear less accurate. We do
not have any way of knowing what frame of reference or what
criteria the doctors used to determine distress in their patients
when they completed the visual analogue scales. Nevertheless we
do know from previous work that doctors tend to exhibit very low
levels of psychosocial probing during consultations (Ford et al,
1996). There is an increasing body of evidence showing that
education programmes for clinicians can improve their recognition
and management of depression (Roter et al, 1995; Stewart, 1996;
Gerrity et al, 1999) and that the general communication skills of
healthcare professionals working within oncology are enhanced
following well structured training courses (Fallowfield et al, 1998;
Baile et al, 1999; Maguire, 1999). 
The magnitude of the problem identified by this study cannot be
overestimated. Cancer incidence in the UK is more than 250 000
per annum and approximately one-third of these patients are likely
to have psychological disorders that merit intervention. The preva-
lence of anxiety and depression following the diagnosis and treat-
ment of cancer does diminish slightly over time but it never
returns to levels seen in the general population even if the treat-
ment has been curative. Not all patients require the help of a
psychiatrist or psychologist, nor are the resources for these
supportive services always available within oncology clinics, so
much of the psychological morbidity has to be managed by oncol-
ogists and specialist nurses. Screening patients using validated
questionnaires prior to seeing the doctor might help improve
detection of potential psychological morbidity and some inter-
esting data have been published showing the acceptability and
utility of automated (touchscreens) screening devices in busy
oncology clinics (Velikova et al, 1999). Patients with high scores
still require proper clinical assessment; if the clinician lacks either
the necessary interviewing skills, or the inclination to probe
further, they can at least refer distressed patients on for more
specialist help on an informed basis. Furthermore there is evidence
for improved efficacy of psychological interventions in screened
populations (Sheard and Maguire, 1999). 
If the manifest psychological distress experienced by patients
with cancer is to be prevented and/or ameliorated then urgent
attention must be given to helping doctors to improve their
communication skills in general and with their recognition of
potentially treatable anxiety and depression. 
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